Share
Peginterferon alfa-2a (Pegasys)
All Clinical Trials
Official Title Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis
Treatments
Lamivudine
, 
Lamivudine
Tradename:Epivir HBVOther Names:3TCClass:Oral Antivirals (Nucleos(t)ide Analogues)Peginterferon alfa-2a
Peginterferon alfa-2a
Tradename:PegasysClass:Immune Modulators (Interferons)Funding
IndustryRoche
References
- Marcellin P, Bonino F, Lau GK, et al. Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a. Gastroenterology. 2009;136:2169-79.
- Marcellin P, Lau GK, Bonino F, et al. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. N Engl J Med. 2004;351:1206-17.
Official Title Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
Phase Phase III
Treatments
Lamivudine
, Lamivudine
Tradename:Epivir HBVOther Names:3TCClass:Oral Antivirals (Nucleos(t)ide Analogues)Peginterferon alfa-2a
Peginterferon alfa-2a
Tradename:PegasysClass:Immune Modulators (Interferons)Funding
IndustryRoche
References
- Lau GK, Piratvisuth T, Luo KX, et al. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med. 2005;352:2682-95.